1. Gardner DK, Sakkas D. Assessment of embryo viability: the ability to select a single embryo for transfer--a review. Placenta. 2003; 24:Suppl B. S5–S12.
2. Gardner DK, Meseguer M, Rubio C, Treff NR. Diagnosis of human preimplantation embryo viability. Hum Reprod Update. 2015; 21(6):727–747.
3. Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990; 344(6268):768–770.
4. Greco E, Bono S, Ruberti A, Lobascio AM, Greco P, Biricik A, et al. Comparative genomic hybridization selection of blastocysts for repeated implantation failure treatment: a pilot study. BioMed Res Int. 2014; 2014:457913.
5. Rubio C, Simón C, Vidal F, Rodrigo L, Pehlivan T, Remohí J, et al. Chromosomal abnormalities and embryo development in recurrent miscarriage couples. Hum Reprod. 2003; 18(1):182–188.
6. Kahraman S, Bahçe M, Samli H, Imirzalioğlu N, Yakisn K, Cengiz G, et al. Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure. Hum Reprod. 2000; 15(9):2003–2007.
7. Orvieto R, Shuly Y, Brengauz M, Feldman B. Should pre-implantation genetic screening be implemented to routine clinical practice? Gynecol Endocrinol. 2016; 32(6):506–508.
9. Preimplantation Genetic Diagnosis International Society. PGDIS position statement on chromosome mosaicism and preimplantation aneuploidy testing at the blastocyst stage. Updated 2016. Accessed July 19, 2016.
http://www.pgdis.org/docs/newsletter_071816.html.
10. Gardner DK, Weissman A, Howles CM, Shoham Z. Textbook of Assisted Reproductive Techniques: Laboratory Perspectives. 4th ed. London: Informa Healthcare;2012.
11. Alfarawati S, Fragouli E, Colls P, Stevens J, Gutiérrez-Mateo C, Schoolcraft WB, et al. The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender. Fertil Steril. 2011; 95(2):520–524.
12. Fragouli E, Alfarawati S, Spath K, Wells D. Morphological and cytogenetic assessment of cleavage and blastocyst stage embryos. Mol Hum Reprod. 2014; 20(2):117–126.
13. Munné S. Chromosome abnormalities and their relationship to morphology and development of human embryos. Reprod Biomed Online. 2006; 12(2):234–253.
14. Hardarson T, Caisander G, Sjögren A, Hanson C, Hamberger L, Lundin K. A morphological and chromosomal study of blastocysts developing from morphologically suboptimal human pre-embryos compared with control blastocysts. Hum Reprod. 2003; 18(2):399–407.
15. Gutiérrez-Mateo C, Colls P, Sánchez-García J, Escudero T, Prates R, Ketterson K, et al. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril. 2011; 95(3):953–958.
17. Voullaire L, Slater H, Williamson R, Wilton L. Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization. Hum Genet. 2000; 106(2):210–217.
18. Fragouli E, Alfarawati S, Spath K, Jaroudi S, Sarasa J, Enciso M, et al. The origin and impact of embryonic aneuploidy. Hum Genet. 2013; 132(9):1001–1013.
20. Minasi MG, Colasante A, Riccio T, Ruberti A, Casciani V, Scarselli F, et al. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Hum Reprod. 2016; 31(10):2245–2254.
22. Paulson RJ. Preimplantation genetic screening: what is the clinical efficiency? Fertil Steril. 2017; 108(2):228–230.
24. Harton GL, Munné S, Surrey M, Grifo J, Kaplan B, McCulloh DH, et al. Diminished effect of maternal age on implantation after preimplantation genetic diagnosis with array comparative genomic hybridization. Fertil Steril. 2013; 100(6):1695–1703.
25. Kang HJ, Melnick AP, Stewart JD, Xu K, Rosenwaks Z. Preimplantation genetic screening: who benefits? Fertil Steril. 2016; 106(3):597–602.